Welcome to our dedicated page for Cbd Global Scien news (Ticker: CBDNF), a resource for investors and traders seeking the latest updates and insights on Cbd Global Scien stock.
Illumination Brands (CBDNF) delivers comprehensive updates on its evolution as a vertically integrated leader in beverage and snack brand incubation. This dedicated news hub provides investors and industry observers with timely access to official announcements, strategic developments, and operational milestones.
Key resources include earnings reports, partnership announcements, product innovation updates, and distribution network expansions. Our curated collection ensures transparent tracking of the company's progress in brand development, manufacturing advancements, and retail channel growth.
Discover updates spanning R&D breakthroughs, new market entries, and leadership initiatives that shape the company's position in functional beverages and consumer goods. Content is rigorously verified to serve as a reliable decision-making tool for stakeholders monitoring this dynamic enterprise.
Bookmark this page for streamlined access to Illumination Brands' verified corporate communications and industry analysis. Regular updates reflect the company's ongoing commitment to innovation in brand incubation and consumer product distribution.
CBD Global Sciences, Inc. (OTC: CBDNF) is facing a Cease Trade Order (CTO) from the Alberta Securities Commission, effective July 23, 2021, due to overdue financial filings for 2020. The issue arose after two of its subsidiaries filed for bankruptcy, impacting the completion of an essential audit. The company is working to finalize its audit by the end of July and anticipates resuming trading soon after. CEO Brad Wyatt expressed optimism about upcoming profitable operations post-COVID, despite the ongoing financial challenges.
CBD Global Sciences Inc. has issued its fourth bi-weekly default status report regarding delays in filing its audited annual financial statements for 2020. The corporation has received a management cease trade order affecting its CEO and CFO due to these delays, but the general public can still trade its shares. The filing is expected to be completed by July 15, 2021. Additionally, the interim financial statements for Q1 2021 will also be delayed until the annual filings are completed. The corporation continues to comply with alternative information guidelines under NP 12-203.
CBD Global Sciences Inc. (CSE: CBDN) updates on its financial filing status, indicating ongoing delays in submitting its audited financial statements for the year ending December 31, 2020. While a management cease trade order is in place for the CEO and CFO, general trading remains unaffected. The company anticipates filing these statements by June 30, 2021, and acknowledges further delays for interim financial statements for Q1 2021. The firm continues to comply with NP 12-203 by issuing bi-weekly updates during the default status.
CBD Global Sciences Inc. has issued a second bi-weekly default status report regarding the delay in filing its audited annual financial statements for the year ended December 31, 2020. The management cease trade order (MCTO) from the Alberta Securities Commission limits trading for executives due to these delays but allows public trading. The Company aims to file the annual statements by June 30, 2021. Interim financial statements for Q1 2021 will also be delayed until after the annual filings. The Company continues to comply with alternative information guidelines.
CBD Global Sciences Inc. has issued a bi-weekly default status report concerning the delay in filing its audited annual financial statements for 2020. A management cease trade order (MCTO) has been imposed, restricting trading by the CEO and CFO until the filings are complete. The audit is ongoing, and the company expects to file the Annual Filings by June 15, 2021. Additionally, interim financial statements for Q1 2021 will also be delayed. The corporation continues to comply with NP 12-203 by providing regular updates on its default status.
CBD Global Sciences Inc. announces that the Alberta Securities Commission has granted a management cease trade order (MCTO) due to a delay in filing its audited annual financial statements for the year ended December 31, 2020. While the MCTO is in effect, the general public can still trade shares, but the CEO and CFO are restricted from trading. The company aims to complete the necessary filings by June 15, 2021, and commits to issuing bi-weekly status reports during this compliance period. There are currently no insolvency proceedings against the company.
CBD Global Sciences Inc. announced delays in filing its annual financial statements and related documents due to COVID-19-related logistical complications. The new anticipated deadline for these filings is June 15, 2021, extending beyond the required date of April 30, 2021. The company is also applying for a Management Cease Trade Order (MCTO) from the Alberta Securities Commission, which would not affect trading for other shareholders. There have been no significant business developments since the last financial statements were filed.
CBD Global Sciences (OTC: CBDNF) has announced the addition of new brands to its CBD distribution channel through Legacy Distribution Group. This includes Mad Tasty, a sugar-free sparkling water with 20 mg of hemp extract. Brad Wyatt, CEO of CBD Global, expressed enthusiasm for the collaboration, noting Mad Tasty's innovative approach in the beverage space. The company aims to strengthen its market presence in Colorado and expand its distribution network. CBD Global continues to operate sustainably, using all-natural methods for hemp cultivation in Colorado.
CBD Global Sciences, Inc. (OTC: CBDNF) has expanded its CBD product distribution by partnering with Legacy Distribution Group to include Marley CBD products. This collaboration will enhance Legacy's offerings in CBD beverages, further establishing its distribution network. CEO Brad Wyatt noted the company's growth in distribution points and the addition of new trucks and drivers to facilitate this expansion. CBD Global continues to develop its market presence through its subsidiaries, offering a range of hemp-derived CBD products, emphasizing quality cultivation practices.
On March 17, 2021, CBD Global Sciences Inc. (OTC: CBDNF) announced an expansion in its distribution channel through the addition of LIFEAID Beverage Co.® products to the portfolio of its subsidiary, Legacy Distribution Group. This partnership aims to enhance the distribution of LIFEAID's hemp-infused beverages, which are well-regarded for their health benefits. CEO Brad Wyatt expressed enthusiasm for the collaboration, highlighting LIFEAID's innovative approach in the CBD space.
FAQ
What is the market cap of Cbd Global Scien (CBDNF)?
